4irj
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
{{STRUCTURE_4irj| PDB=4irj | SCENE= }} | {{STRUCTURE_4irj| PDB=4irj | SCENE= }} | ||
===Structure of the mouse CD1d-4ClPhC-alpha-GalCer-iNKT TCR complex=== | ===Structure of the mouse CD1d-4ClPhC-alpha-GalCer-iNKT TCR complex=== | ||
+ | {{ABSTRACT_PUBMED_23960235}} | ||
==Function== | ==Function== | ||
Line 9: | Line 10: | ||
==Reference== | ==Reference== | ||
- | <references group="xtra"/><references/> | + | <ref group="xtra">PMID:023960235</ref><references group="xtra"/><references/> |
[[Category: Mus musculus]] | [[Category: Mus musculus]] | ||
[[Category: Nemcovic, M.]] | [[Category: Nemcovic, M.]] |
Revision as of 08:57, 4 September 2013
Contents |
Structure of the mouse CD1d-4ClPhC-alpha-GalCer-iNKT TCR complex
Template:ABSTRACT PUBMED 23960235
Function
[CD1D1_MOUSE] Antigen-presenting protein that binds self and non-self glycolipids and presents them to T-cell receptors on natural killer T-cells.[1] [2] [3] [B2MG_MOUSE] Component of the class I major histocompatibility complex (MHC). Involved in the presentation of peptide antigens to the immune system.
About this Structure
4irj is a 4 chain structure with sequence from [1] and Mus musculus. Full crystallographic information is available from OCA.
Reference
- Aspeslagh S, Nemcovic M, Pauwels N, Venken K, Wang J, Van Calenbergh S, Zajonc DM, Elewaut D. Enhanced TCR Footprint by a Novel Glycolipid Increases NKT-Dependent Tumor Protection. J Immunol. 2013 Aug 19. PMID:23960235 doi:10.4049/jimmunol.1203134
- ↑ Jayawardena-Wolf J, Benlagha K, Chiu YH, Mehr R, Bendelac A. CD1d endosomal trafficking is independently regulated by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain. Immunity. 2001 Dec;15(6):897-908. PMID:11754812
- ↑ Zajonc DM, Maricic I, Wu D, Halder R, Roy K, Wong CH, Kumar V, Wilson IA. Structural basis for CD1d presentation of a sulfatide derived from myelin and its implications for autoimmunity. J Exp Med. 2005 Dec 5;202(11):1517-26. Epub 2005 Nov 28. PMID:16314439 doi:10.1084/jem.20051625
- ↑ Zajonc DM, Cantu C 3rd, Mattner J, Zhou D, Savage PB, Bendelac A, Wilson IA, Teyton L. Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor. Nat Immunol. 2005 Aug;6(8):810-8. Epub 2005 Jul 10. PMID:16007091 doi:10.1038/ni1224